Literature DB >> 15163303

Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain.

I J McEwan1.   

Abstract

The androgen receptor is a ligand-activated transcription factor that binds DNA response elements as a homodimer. Binding sites for the receptor have been identified both upstream and downstream of the transcription start site. Once bound to DNA, the receptor contacts chromatin remodelling complexes, coactivator proteins and components of the general transcription machinery in order to regulate target gene expression. The main transactivation domain, termed AF1, is located within the structurally distinct amino-terminal domain. This region is structurally flexible but adopts a more folded conformation in the presence of the binding partner TFIIF, and this in turn enhances subsequent protein-protein interactions. Thus, there is likely to be a dynamic interplay between protein-protein interactions and protein folding, involving AF1, that is proposed to lead to the assembly and/or disassembly of receptor-dependent transcription complexes. Copyright 2004 Society for Endocrinology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163303     DOI: 10.1677/erc.0.0110281

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  37 in total

Review 1.  Disruption of androgen receptor signaling in males by environmental chemicals.

Authors:  Doug C Luccio-Camelo; Gail S Prins
Journal:  J Steroid Biochem Mol Biol       Date:  2011-04-13       Impact factor: 4.292

Review 2.  Chemistry and structural biology of androgen receptor.

Authors:  Wenqing Gao; Casey E Bohl; James T Dalton
Journal:  Chem Rev       Date:  2005-09       Impact factor: 60.622

Review 3.  Structural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors.

Authors:  Vincent J Hilser; E Brad Thompson
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

Review 4.  Maintaining and reprogramming genomic androgen receptor activity in prostate cancer.

Authors:  Ian G Mills
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

Review 5.  Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Andrew P Lieberman
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

6.  C/EBPalpha redirects androgen receptor signaling through a unique bimodal interaction.

Authors:  J Zhang; M Gonit; M D Salazar; A Shatnawi; L Shemshedini; R Trumbly; M Ratnam
Journal:  Oncogene       Date:  2009-11-09       Impact factor: 9.867

7.  Genome-wide DNA methylation profiling of CpG islands in hypospadias.

Authors:  Shweta Choudhry; Archana Deshpande; Liang Qiao; Kenneth Beckman; Saunak Sen; Laurence S Baskin
Journal:  J Urol       Date:  2012-08-17       Impact factor: 7.450

8.  Identification of androgen receptor phosphorylation in the primate ovary in vivo.

Authors:  Iain J McEwan; Dagmara McGuinness; Colin W Hay; Robert P Millar; Philippa T K Saunders; Hamish M Fraser
Journal:  Reproduction       Date:  2010-04-20       Impact factor: 3.906

9.  Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element.

Authors:  Marilena Lanzino; Diego Sisci; Catia Morelli; Cecilia Garofalo; Stefania Catalano; Ivan Casaburi; Claudia Capparelli; Cinzia Giordano; Francesca Giordano; Marcello Maggiolini; Sebastiano Andò
Journal:  Nucleic Acids Res       Date:  2010-04-26       Impact factor: 16.971

10.  A novel androgen receptor amino terminal region reveals two classes of amino/carboxyl interaction-deficient variants with divergent capacity to activate responsive sites in chromatin.

Authors:  Eleanor F Need; Howard I Scher; Amelia A Peters; Nicole L Moore; Albert Cheong; Charles J Ryan; Gary A Wittert; Villis R Marshall; Wayne D Tilley; Grant Buchanan
Journal:  Endocrinology       Date:  2009-03-12       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.